Mohs Surgeons Favor Nicotinamide for Chemoprevention in Survey Mohs Surgeons Favor Nicotinamide for Chemoprevention in Survey

Overall, 76.9% of the respondents said they recommended nicotinamide for preventing keratinocyte carcinomas and 20% said they had recommended nicotinamide to more than 100 patients in the past year.Medscape Medical News
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Dermatology News Source Type: news